scholarly journals Evaluation of lipid profile and its relationship with blood pressure in patients with Cushing’s disease

2018 ◽  
Vol 7 (5) ◽  
pp. 637-644 ◽  
Author(s):  
Lang Qin ◽  
Xiaoming Zhu ◽  
Xiaoxia Liu ◽  
Meifang Zeng ◽  
Ran Tao ◽  
...  

Introduction The purpose of the study was to describe lipid profile and explore pathogenetic role of LDL-c on hypertension in patients with Cushing’s disease (CD). Hypertension is a common feature in patients with CD. Previous study found low-density lipoprotein cholesterol (LDL-c) uptake in vascular cells might be involved in vascular remodeling in patients with CD. Therefore, we evaluated the relationship between lipid profile and the blood pressure in patients with CD. Methods This retrospective study included 84 patients referred to Huashan Hospital for the evaluation and diagnosis of CD from January 2012 to December 2013. All subjects had detailed clinical evaluation by the same group of endocrinology specialists to avoid subjective influences. Results We found that high LDL-c patients had significant higher body mass index (BMI), systolic blood pressure (SBP), cholesterol (CHO), triglyceride (TG), and apolipoproteinB (apoB) (P < 0.05). An association was detected between SBP values and lipids profile including CHO, TG, LDL-c, apolipoproteinA (apoA), apoB and lipoprotein(a) (LP(a)). After adjustment for all covariates, the LDL-c remained positively associated with SBP. In patients with or without taking statins, patients with LDL-c ≥3.37 mmol/L had higher SBP than patients with LDL-c <3.37 mmol/L. Then, LDL-c was coded using restricted cubic splines (RCS) function with three knots located at the 5th, 50th and 95th percentiles of the distribution of LDL-c. Compared to individuals with 3.215 mmol/L of LDL-c, individuals with 4.0, 4.5 and 5.0 mmol/L of LDL-c had differences of 3.86, 8.53 and 14.11 mmHg in SBP, respectively. Conclusions An independent association between LDL-c and SBP was found in patients with CD. We speculate that LDL-c may be a pathogenic factor for hypertension in those patients.

2010 ◽  
Vol 162 (4) ◽  
pp. 677-684 ◽  
Author(s):  
Charlotte Höybye ◽  
Oskar Ragnarsson ◽  
Peter J Jönsson ◽  
Maria Koltowska-Häggström ◽  
Peter Trainer ◽  
...  

ObjectivePatients in remission from Cushing's disease (CD) have many clinical features that are difficult to distinguish from those of concomitant GH deficiency (GHD). In this study, we evaluated the features of GHD in a large cohort of controlled CD patients, and assessed the effect of GH treatment.Design and methodsData were obtained from KIMS, the Pfizer International Metabolic Database. A retrospective cross-sectional comparison of background characteristics in unmatched cohorts of patients with CD (n=684, 74% women) and nonfunctioning pituitary adenoma (NFPA;n=2990, 39% women) was conducted. In addition, a longitudinal evaluation of 3 years of GH replacement in a subset of patients with controlled CD (n=322) and NFPA (n=748) matched for age and gender was performed.ResultsThe cross-sectional study showed a significant delay in GHD diagnosis in the CD group, who had a higher prevalence of hypertension, fractures, and diabetes mellitus. In the longitudinal, matched study, the CD group had a better metabolic profile but a poorer quality of life (QoL) at baseline, which was assessed with the disease-specific questionnaire QoL-assessment of GHD in adults. After 3 years of GH treatment (mean dose at 3 years 0.39 mg/day in CD and 0.37 mg/day in NFPA), total and low-density lipoprotein cholesterol decreased, while glucose and HbAlc increased. Improvement in QoL was observed, which was greater in the CD group (−6 CD group versus −5 NFPA group,P<0.01).ConclusionIn untreated GHD, co-morbidities, including impairment of QoL, were more prevalent in controlled CD. Overall, both the groups responded similarly to GH replacement, suggesting that patients with GHD due to CD benefit from GH to the same extent as those with GHD due to NFPA.


Author(s):  
Gabriel Olukayode Ajayi ◽  
Elvis Uchechukwu Obi ◽  
Elizabeth Namesegua Elegbeleye ◽  
Precious Titilayo Obayemi ◽  
Oyindamola Mary Edamisan

Diabetes mellitus is a non-communicable disease which has been associated with liver and kidney injuries, and at the same time affects lipid profiles. The aim of this study was to investigate the role of Vernonia amygdalina (VAM) on plasma lipid profile, liver and kidney enzymes in rats with streptozotocin -induced diabetes. Twenty-five male albino wistar rats weighing between 137 and 223 g were randomly grouped into five of five rats per group as follows: control, diabetic, diabetic + metformin (MET), diabetic + VAM at 150, 300 mg/kg. Diabetes was induced by administration of 45 mg/kg body weight streptozotocin (STZ) dissolved in citrate buffer (0.01 M, pH 4.5) by single intraperitoneal injection. Three days after, when diabetes was confirmed, MET and VAM were administered daily by oral gavage for 7 days. Animals were fasted overnight after the last administration of MET and VAM, sacrificed, blood was collected and plasma prepared for lipid profile estimation. Liver and kidney were collected, weighed, homogenized and supernatants obtained for enzymes and biochemical assays. There were no significant (p>0.05) change in the weights of animal, liver and kidney, liver/rat and kidney/rat ratios, plasma cholesterol (CHOL) concentration, activities of liver and kidney aspartate aminotransferase (AST), alanine aminotransferase (ALT), liver gamma-glutamyl transferase (GGT), lactate dehydrogenase (LDH), and liver and kidney total protein (TPRO) concentrations; significant (p<0.05) decrease in triglyceride (TRIG), high density lipoprotein-cholesterol (HDL), low density lipoprotein-cholesterol (LDL), very low density lipoprotein-cholesterol (VLDL); and significant (p<0.05) increase in fasting blood glucose (FBG) level, kidney GGT, LDH activities, liver and kidney creatinine (CREA) and total bilirubin (TBIL) concentrations of diabetic (STZ) rats compared with normal control. The treatment of the diabetic rats with MET and VAM significantly modulated positively these parameters compared with the diabetic rats. This study further explains the protective role played by VAM in dyslipidaemia, liver and kidney injuries resulting from diabetes.


Author(s):  
Sheena Chopra ◽  
Sangeeta Pahwa

Background: Preeclampsia is associated with adverse pregnancy outcome and is a major cause of the fetomaternal morbidity and mortality. This study aimed at finding the role of lipid profile and uterine artery Doppler as a reliable predictor of risk of preeclampsia in early second trimester.Methods: This study is conducted in the obstetrics and gynecology department of a tertiary care teaching hospital, Amritsar. Lipid profile and Uterine artery doppler is estimated in 100 antenatal women from 14-20 weeks of period of gestation who met the inclusion criteria and are followed up till delivery or till preeclampsia sets in.Results: Out of 100 subjects 74 remained normotensive (Group A) and 26 developed preeclampsia (Group B). The mean serum level of total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL) and very low-density lipoprotein cholesterol (VLDL) was significantly higher in Group B as compared to group A women. The Preeclamptic women showed significant fall in high density lipoprotein cholesterol (HDL) level as compared to normal pregnant women. The mean S/D ratio, PI and RI values of uterine artery Doppler were higher for group B and were statistically significant.Conclusions: The combined predictive value of lipid profile and uterine artery Doppler for estimating risk of preeclampsia was more reliable than of any of the test individually.


Author(s):  
Д.П. Покусаева ◽  
И.А. Аниховская ◽  
Л.А. Коробкова ◽  
М.Ю. Яковлев

В последние годы большое внимание уделяется роли микробиоты в атерогенезе с позиций воспалительной теории. На основании экспериментальных и клинических данных была сформулирована эндотоксиновая теория атеросклероза. Подтверждением важной роли кишечного липополисахарида в атерогенезе является возрастная динамика показателей системной эндотоксинеми и липидного профиля. Цель исследования - выявление взаимосвязи между показателями системной эндотоксинемии и факторами риска атеросклероза, в аспекте возрастных и гендерных различий. Методика. Обследовано 113 пациентов среднего возраста. Все пациенты прошли оценку факторов риска развития атеросклероза по шкале SCORE. Пациенты были отнесены к средней группе риска (до 5%), оценивали себя как «здоровые», жалоб на момент обследования не предъявляли. Индекс массы тела был до 30 кг/м2. Определялись показатели липидного профиля (анализатор «StatFax 3300», США, реактивы «Analyticon», Германия): уровень общего холестерина, липопротеинов высокой плотности и уровень триглицеридов, рассчитывался индекс атерогенности и концентрация липопротеинов низкой плотности. Определялись параметры системной эндотоксинемии: концентрации липополисахарида (микро-ЛАЛ-тест), уровень антител к гидрофобной и гидрофильной частям молекулы ЛПС методом «СОИС-ИФА». Результаты. Выявлена прямая значимая корреляция концентрации общего холестерина, липопротеинов низкой плотности и липопротеинов высокой плотности в зависимости от возраста. При построении регрессионной модели зависимости показателей системной эндотоксинемии от пола и возраста пациентов не выявлено. При визуальной оценке графиков обращает внимание наличие у женщин тенденции к возрастному повышению уровня липополисахарида и снижению концентрации антител к гидрофильной части молекулы липополисахарида. Обнаружены гендерные различия показателей липидного профиля и уровня липополисахарида. Заключение. Статистически значимая возрастная динамика показателей липидного профиля при тенденции к нарастанию уровня липополисахарида, а также снижение концентрации антител к гидрофильной части молекула липополисахарида, имеющее определённые гендерные различия, свидетельствует о целесообразности продолжения исследований с увеличением числа обследованных в расширенном возрастном диапазоне. Atherosclerosis is a polyetiologic disease. In recent years, much attention has been paid to the role of the microbiota in atherogenesis from the perspective of inflammatory theory. Based on experimental and clinical data, the endotoxin theory of atherosclerosis was formulated. Confirmation of the important role of intestinal lipopolysaccharide in atherogenesis is the age dynamics of systemic endotoxemia parametrs and lipid profile. The goal of our study was to identify the relationship between the indicators of systemic endotoxemia and the generally accepted risk factors for atherosclerosis, especially the age dynamics and the influence of gender. Methods. We examined 113 patients middle age. All patients were assessed for risk factors for atherosclerosis according to the SCORE scale. Patients were assigned to the average risk group (up to 5%), rated themselves as “healthy”, did not present any complaints at the time of the survey. The body mass index was up to 30 kg/m2. Indicators of the lipid profile were determined («StatFax» 3300 analyzer, USA, «Analyticon» reagents, Germany): the level of total cholesterol, high-density lipoprotein and triglyceride levels, the atherogenic index and the concentration of low-density lipoprotein were calculated. The parameters of systemic endotoxemia were determined: the concentration of lipopolysaccharide using a micro-LAL test, the level of antibodies to the hydrophobic and hydrophilic parts of the lipopolysaccharide molecule using the “SOIS-ELISA” method. Results. A direct significant correlation was found between the concentration of total cholesterol, low-density lipoprotein and high-density lipoprotein, depending on age. When constructing a regression model of the age dynamics, the concentrations of lipopolysaccharides, antibodies to the hydrophobic and hydrophilic parts of the lipopolysaccharide molecule were not detected (p> 0.05). When adjusted for gender, the age dynamics of systemic endotoxemia was also not observed. When visually assessing the graphs, attention is drawn to the fact that women have an age-related tendency to increase the level of lipopolysaccharide and a decrease in the concentration of antibodies to the hydrophilic part of the lipopolysaccharide molecule. In addition, gender differences in lipid profile and lipopolysaccharide levels were found. Conclusion. The significant age-related dynamics of the lipid profile in the presence of a tendency to an increase in the level of lipopolysaccharide and a decrease in the concentration of antibodies to the hydrophilic part of the lipopolysaccharide molecule, which has certain gender differences, revealed the necessity and feasibility of continuing research with an increase in the number of subjects and in the extended age range.


2019 ◽  
Vol 17 (5) ◽  
pp. 498-514 ◽  
Author(s):  
Genovefa D. Kolovou ◽  
Gerald F. Watts ◽  
Dimitri P. Mikhailidis ◽  
Pablo Pérez-Martínez ◽  
Samia Mora ◽  
...  

: Residual vascular risk exists despite the aggressive lowering of Low-Density Lipoprotein Cholesterol (LDL-C). A contributor to this residual risk may be elevated fasting, or non-fasting, levels of Triglyceride (TG)-rich lipoproteins. Therefore, there is a need to establish whethe a standardised Oral Fat Tolerance Test (OFTT) can improve atherosclerotic Cardiovascular (CV) Disease (ASCVD) risk prediction in addition to a fasting or non-fasting lipid profile. : An expert panel considered the role of postprandial hypertriglyceridaemia (as represented by an OFTT) in predicting ASCVD. The panel updated its 2011 statement by considering new studies and various patient categories. The recommendations are based on expert opinion since no strict endpoint trials have been performed. : Individuals with fasting TG concentration <1 mmol/L (89 mg/dL) commonly do not have an abnormal response to an OFTT. In contrast, those with fasting TG concentration ≥2 mmol/L (175 mg/dL) or nonfasting ≥2.3 mmol/L (200 mg/dL) will usually have an abnormal response. We recommend considering postprandial hypertriglyceridaemia testing when fasting TG concentrations and non-fasting TG concentrations are 1-2 mmol/L (89-175 mg/dL) and 1.3-2.3 mmol/L (115-200 mg/dL), respectively as an additional investigation for metabolic risk prediction along with other risk factors (obesity, current tobacco abuse, metabolic syndrome, hypertension, and diabetes mellitus). The panel proposes that an abnormal TG response to an OFTT (consisting of 75 g fat, 25 g carbohydrate and 10 g proteins) is >2.5 mmol/L (220 mg/dL). : Postprandial hypertriglyceridaemia is an emerging factor that may contribute to residual CV risk. This possibility requires further research. A standardised OFTT will allow comparisons between investigational studies. We acknowledge that the OFTT will be mainly used for research to further clarify the role of TG in relation to CV risk. For routine practice, there is a considerable support for the use of a single non-fasting sample.


2014 ◽  
Vol 9 (1) ◽  
pp. 13-17 ◽  
Author(s):  
CM Reza ◽  
ASMA Kabir ◽  
Tuhin Biswas ◽  
Kamrun Nahar Choudhury ◽  
Md Zahidur Rahman ◽  
...  

Back ground: Hypertension and dyslipidemia are associated with oxidative stress and are major causes of cardiovascular disease amounting to 30% of global death rate. It is widely accepted that cardiovascular disease is associated with hypertension and increased blood levels of low-density lipoprotein (LDL), total cholesterol (TC), and triglycerides. In contrast, a low level of high density lipoprotein (HDL) is a risk factor for mortality from cardiovascular disease. Hypertension is a major public health problem in developed and developing countries. Methods: This study was a cross sectional study in which 159 diagnosed hypertensive patient and 75 with normal blood pressure (normotensive) were enrolled. These patients sought a through health cheek up including blood pressure assessment between May 2012 to April 2013 in Tairunnessa Memorial Medical College and Hospital. Lipid parameter total cholesterol (TC), triglyceride (TG), low density lipoprotein ( LDLc) and high density lipoprotein (HDLc) were estimated by enzymatic colorimetric test. Results: The mean of Systolic blood pressure and Diastolic blood pressure of hypertensive were higher than normotensive (p<0.001). The serum levels of total cholesterol, triglyceride and LDL-C in hypertensive subject were higher than normotensive and statistically significant (p<0.001). Serum HDL-C was significantly lower (p<0.001) in hypertensive patients than in normotensive. Conclusion: Analytical results of the study revealed that hypertensive patients have been found to have close association with dyslipidemia. Hypertension and dyslipidemia can be modified either by proper life style changes or medical management or by the combination of the both. This study suggests that hypertensive patients need measurement of blood pressure and lipid profile at regular interval to prevent heart diseases and stroke. DOI: http://dx.doi.org/10.3329/uhj.v9i1.19505 University Heart Journal Vol. 9, No. 1, January 2013; 13-17


2016 ◽  
Vol 5 (2) ◽  
pp. 30-34 ◽  
Author(s):  
Muhammad Naeem ◽  
Rehman Mehmood Khattak ◽  
Mati Ur Rehman ◽  
Muhammad Nasir Khan Khattak

Patients with diabetes are considered to be at more risk of dyslipidemia and hypertension, hence targets for cardiovascular diseases. This study describes the possible role of Glycated Hemoglobin (HbA1c) and serum lipid profile as a biomarker in the detection of cardiovascular diseases. A cross-sectional study was carried out on 54 (33 males and 21 females) type 2 diabetes (T2DM) patients at Ayub Teaching Hospital (ATH), Abbottabad and Mardan Medical Complex (MMC), Mardan, Khyber Pukhtunkhwa (KP), Pakistan. The control group comprised of 20 (13 males and 7 females) healthy human samples. The patients had significantly higher (p<0.05) Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), HbA1c, Fasting Blood Glucose (FBG), Total Cholesterol (TC), Triglyceride (TG) compared to control subjects. Only High Density Lipoprotein (HDL) was found to be significantly (p<0.05) lower in the patients compared to controls. With regards to gender, in the female patients SBP, DBP, TC and Low Density Lipoprotein (LDL) were significantly higher (p<0.05) compared to males patients. The HbA1c was found to be significantly higher (p<0.05) in males. Results also revealed that patients having HbA1c>7.0%, had higher TG than those with HbA1c?7.0%. Furthermore, 14.2% patients with HbA1c>7.0% had cerebrovascular diseases and 28% have ischemic heart diseases. The findings of the current study suggests association of HbA1c with lipid profile in T2DM patients and both might be used as a predictor of cardiovascular diseases in such patients.South East Asia Journal of Public Health Vol.5(2) 2015: 30-34


2018 ◽  
Vol 16 (2) ◽  
pp. 175-177
Author(s):  
Gita Khakurel ◽  
Rajat Kayastha ◽  
Sanat Chalise ◽  
Prabin K Karki

Background: Hyperlipidemia is one of the important risk factor for development of cardiovascular disease in post menopausal women.Our study compared the serum lipid profile and atherogenic index of plasma between premenopausal and post menopausal women.Methods: This was a cross sectional study conducted in Kathmandu Medical College. A total number of 194 women in the age group 30 to 60 years were studied. They include 108 postmenopausal women and 86 premenopausal controls. Total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol and triglycerides were determined. Results: The mean value of total cholesterol, low-density lipoprotein cholesterol and triglyceride were significantly increased in postmenopausal women when compared to premenopausal women. There was increase in high-density lipoprotein cholesterol in postmenopausal women but the difference was not significant. The atherogenic index of plasma was increased in postmenopausal women (0.22 ± 0.25 mmol/l). This shows that postmenopausal women in our setting are at medium risk of developing cardiovascular disease. Atherogenic index of plasma was positively and significantly correlated with age (r= 0.29, p<0.05), body mass index (r=0.24, p<0.05), systolic blood pressure (r=0.20, p<0.05) and diastolic blood pressure (r=0.45, p<0.05).Conclusions: Postmenopausal women were at greater risk for developing cardiovascular disease when compared to premenopausal women due to increase in atherogenic lipid profile. There was a significant correlation of atherogenic index of plasma with age, body mass index, systolic blood pressure and diastolic blood pressure.Keywords: Keywords: Atherogenic index of plasma; lipid profile; menopause.


2017 ◽  
Vol 95 (8) ◽  
pp. 735-741
Author(s):  
Evgeniya V. Sevostyanova ◽  
Yu. A. Nikolaev ◽  
I. M. Mitrofanov ◽  
V. Ya. Polyakov ◽  
N. A. Dolgova

Purpose. To study the dependence of the frequency of occurrence and the values of indicators of basic risk factors for chronic non-communicable diseases on the degree of transnosological polymorbidity in patients of a clinic of general therapeutic profile for the period from 2003 to 2013. Material and methods. The analysis of 5019 medical records (2501 men, 2518 women) treated in the clinic of RIECM, Novosibirsk, was carried out. Transnosological polymorbidity was evaluated from the average number of nosologies in accordance with the International Classification of Diseases, 10th revision (ICD-10). The following risk factors were assessed based on clinical and laboratory tests: high blood pressure, increased concentration of total cholesterol, low density lipoprotein cholesterol, triglycerides, glucose, uric acid, decreased concentration of high density lipoprotein cholesterol, obesity. Results. The dependence of the values of indicators and frequency of occurrence of chronic non-communicable diseases risk factors on the degree of polymorbidity, taking into account gender differences, was studied. In both men and women, increased transnosological polymorbidity index was associated with the growth of indicators of main non-communicable risk factors: systolic blood pressure, diastolic blood pressure, glucose, low density lipoprotein cholesterol, uric acid in the blood. In men, a more pronounced increase with growing polymorbidity index was especially noticeable in the body mass index and blood glucose; in women in blood glucose and triglyceride levels. Conclusion. The study demonstrated the important role of risk factors of chronic non-communicable diseases that collectively represent clinical manifestations of metabolic syndrome in the development of polymorbidity in patients of therapeutic profile. These findings indicate the need of differential prevention and treatment of patients with polymorbidity together with mandatory identification and correction of modifiable risk factors of chronic non-communicable diseases.


2019 ◽  
Vol 6 (4) ◽  
pp. 1303
Author(s):  
Mahendrapal Singh ◽  
Mohd. Imran Khan ◽  
A. C. Gupta ◽  
Richa Giri ◽  
Ashfak Alam

Background: Cirrhosis is defined anatomically as a diffuse process with fibrosis and nodule formation. It is the result of the fibrogenesis that occurs with chronic liver injury. For reduced liver biosynthesis capacity, low level of serum cholesterol, low density lipoprotein (LDL) and high density lipoprotein (HDL) is usually observed in the chronic liver disease. Due to the high prevalence of chronic liver disease in our country we have conducted this study to determine role of lipid profile in a patient with cirrhosis and to assess its relationship to the severity of cirrhosis.Methods: In this cross-sectional study, patients classified in 3 groups as per CTP classification for severity of cirrhosis. Serum lipid profile was observed in these patients. The primary aim was to assess changes in various parameters of lipid profile and its relationship with severity of liver cirrhosis.Results: About 74 cirrhotic patients were enrolled, 20 in class A, 25 in class B and 29 in class C. serum lipid profile was observed in these patients. Serum cholesterol and HDL cholesterol were decreased with increasing severity of cirrhosis. Serum triglyceride level increases with progression of cirrhosis and very low density lipoprotein (VLDL) level has no correlation with severity of cirrhosis.Conclusions: Serum cholesterol and HDL level decreases with progression of cirrhosis. In future serum lipid profile can be used in classification criteria for assessing severity of liver cirrhosis.


Sign in / Sign up

Export Citation Format

Share Document